With more education around and access to naloxone in public spaces, anyone has the power to help save a life. Use as directed. https://lnkd.in/gzH2yuWt
Emergent BioSolutions
Biotechnology Research
Gaithersburg, Maryland 43,066 followers
Protecting against emerging global health threats.
About us
At Emergent, we develop, manufacture, and deliver protections against public health threats. For more than two decades, we’ve been at work defending people from things we hope will never happen — so that we’re prepared, just in case they ever do. Please note: It has come to our attention that there may be people posing as Emergent recruiters and hiring managers online, offering fraudulent opportunities to job seekers. Emergent will never ask for any financial commitment from a candidate as a pre-employment requirement. Learn more about recruitment fraud and how to protect yourself here: https://bit.ly/recruitment-fraud
- Website
-
https://www.emergentbiosolutions.com/
External link for Emergent BioSolutions
- Industry
- Biotechnology Research
- Company size
- 1,001-5,000 employees
- Headquarters
- Gaithersburg, Maryland
- Type
- Public Company
- Founded
- 1998
- Specialties
- Manufacturing, Partnering, M&A, Devices Development, Vaccine Development, Therapeutics Development, and Contract Development and Manufacturing
Locations
Employees at Emergent BioSolutions
-
Victor Cascella
Sr. Director at Emergent BioSolutions
-
Stephanie Duatschek
BioPharm Executive| Board Facing| Strategy & Operational Leader| Transformational Leader
-
Sarah Royalty Tredo
BioTech/Pharma Global Strategic Commercial Leader
-
Elissa S. Cote
Biopharmaceutical Executive | Strategic, Commercial & Operational Leader
Updates
-
By expanding access to naloxone, Emergent is empowering more people to help save lives from opioid overdose. Read more from our President and CEO in the The Wall Street Journal about how Emergent is tackling some of the biggest public health challenges facing us today. Use as directed. https://lnkd.in/deYrXWBV
Paid Program: Fighting the Opioid Overdose Crisis
partners.wsj.com
-
Today Emergent announced that it has received a $50 million contract option for the acquisition of CYFENDUS® (Anthrax Vaccine Adsorbed, Adjuvanted). Learn more: https://lnkd.in/eemJ9Qu9
Emergent BioSolutions Receives $50 Million Contract Option from BARDA to Procure Doses of CYFENDUS® (Anthrax Vaccine Adsorbed, Adjuvanted)
investors.emergentbiosolutions.com
-
Access is critical in the fight against opioid overdose deaths. Read more about how expanded access to naloxone is helping to save lives. https://lnkd.in/gRC2ZFwv
Narcan vending machines help communities save fentanyl users' lives - UPI.com
upi.com
-
Opioid overdose deaths remain a public health threat throughout Canada. More education around naloxone and the potential dangers of fentanyl can help. https://lnkd.in/gej4S76t
Edmonton registers the highest opioid-related deaths in Alberta with more under review
edmontonjournal.com
-
tara sundem of Hushabye Nursery joined Countermeasures to talk about the benefit of providing a non-judgmental, trauma-informed environment for new mothers and families affected by the opioid crisis. https://lnkd.in/g7etcETd
-
Nikole Young of Heart Rock Justus Family Recovery Center joined Countermeasures to speak about the importance of education and understanding when it comes to new mothers affected by the opioid crisis. Listen and subscribe: https://lnkd.in/g6GP2Y7Y
-
As the threat of opioid overdose continues transforming lives across Canada, Emergent is working to broaden access to naloxone to help save lives from opioid overdose. https://lnkd.in/erV2pB9a
Opioid overdose crisis prompts calls for education and broader access to life-saving medications
theglobeandmail.com
-
Ask Eirik Storsve, Senior Director, Government Affairs, recently presented at the Berlin Security Conference, as part of a panel discussion on the critical need for preparedness to enhance resilience.
-
Affiliated pages
Similar pages
Browse jobs
Stock
EBS
NYSE
20 minutes delay
$8.10
0.04 (0.496%)
- Open
- 7.85
- Low
- 7.7
- High
- 8.35
Data from Refinitiv
See more info on